Context Non-visible haematuria (NVH) is a common finding and may indicate undiagnosed
urological cancer. The optimal investigation of NVH is unclear, given the incidence of cancer …

Background We examined the usefulness of the nuclear matrix protein 22 (NMP22)
BladderChek test for detecting bladder cancer. Materials and Methods A literature search …

Importance Microhematuria (MH) is a common finding that often leads to further evaluation
for urinary tract cancers. There is ongoing debate about the extent to which patients with MH …

BACKGROUND: We compared the diagnostic utilities of CYFRA 21‐1, nuclear matrix protein-
22 (NMP22), urinary bladder cancer antigen (UBC), and fibrin/fibrinogen degradation …

Objectives: The standard initial approach in patients with hematuria or other symptoms
suggestive of bladder cancer (BC) is a combination of cystoscopy and urine cytology (UC); …

Microscopic hematuria (MH), often discovered incidentally, has many causes, including
benign processes, kidney disease, and genitourinary malignancy. The clinician, therefore …

Objective: To analyze gender-specific differences regarding clinical symptoms, referral
patterns and tumor biology prior to initial diagnosis of urothelial carcinoma of the bladder …

Introduction. Several point‐of‐care tests (POCT) are available for the diagnosis of bladder
cancer (BC). We evaluate the impact of HU (hematuria) on performance of POCTs. Materials …

Methods MEDLINE was searched between January 1990 and June 8, 2018. The positive
predictive value (PPV) of MH as a screening tool for urologic malignancy was calculated for …

The diagnosis of bladder cancer is generally made by cystoscopy and biopsy. Moreover,
bladder cancer has a very high frequency of recurrence and therefore requires follow-up …